Pharmacology & Toxicology Research

Cardiovascular

Overview

  • Cardiovascular diseases are the leading cause of deaths globally.
  • Our faculty include researchers focused on better understanding causes of cardiovascular diseases and identifying novel pharmacological targets in treating such diseases.

Research Approaches

  • Atherogenesis
  • hypertension and renal injury
  • obesity-related damage
  • vascular cell signaling

 

Faculty Research Interests

Dr. Gungbi Li PhD

Guangbi (George) Li, Ph.D., Assistant Professor

Detailed research overview for Dr. Guangbi Li

  • Exosome-mediated intercellular communication in glomerular disease.
  • Renal medullary regulation of blood pressure by telocyte-derived exosomes.
  • Podocyte Piezo1 channel in mechanosensing of glomerular hyperfiltration.
  • Ceramide metabolism in podocytopathy and nephrotic syndrome.
  • TRPML1 channel in lysosomal regulation of exosome release.

Dr. Ningjun Li PhD

Ningjun Li, Ph.D., Professor

Detailed research overview for Dr. Ningjun Li

    • Renal sphingolipid signaling and hypertension
    • Sphingosine kinases in cisplatin-induced nephrotoxicity
    • Endocannabinoid system in kidney injury and disease progression
    • Renal α7 nicotinic acetylcholine receptor function
    • Fructose-induced salt-sensitive hypertension and hypoxia signaling

Dr. Pin-Lan LI MD PhD

Pin-Lan Li, M.D., Ph.D., Professor

Detailed research overview for Dr. Pin-Lan Li

  • Molecular mechanisms of podocytopathy and associated hypertension.
  • Blood pressure regulation by endocannabinoid and exosomes in the renal medulla.
  • Lipid raft redox signaling platforms in coronary endothelial cells.
  • Inflammasome activation in hyperhomocysteinemia-induced glomerular disease.
  • Novel second messengers – cADP-ribose and NAADP in arterial myocytes